- Home
- ORGO vs BSVN Comparison
ORGO vs BSVN Comparison
Compare ORGO & BSVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- BSVN
- Stock Information
- Founded
- ORGO 1985
- BSVN 2004
- Country
- ORGO United States
- BSVN United States
- Employees
- ORGO N/A
- BSVN N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- BSVN Major Banks
- Sector
- ORGO Health Care
- BSVN Finance
- Exchange
- ORGO Nasdaq
- BSVN Nasdaq
- Market Cap
- ORGO 384.4M
- BSVN 370.9M
- IPO Year
- ORGO N/A
- BSVN 2018
- Fundamental
- Price
- ORGO $3.46
- BSVN $40.25
- Analyst Decision
- ORGO Buy
- BSVN Buy
- Analyst Count
- ORGO 2
- BSVN 2
- Target Price
- ORGO $5.50
- BSVN $51.00
- AVG Volume (30 Days)
- ORGO 911.8K
- BSVN 21.7K
- Earning Date
- ORGO 08-07-2025
- BSVN 07-10-2025
- Dividend Yield
- ORGO N/A
- BSVN 2.39%
- EPS Growth
- ORGO N/A
- BSVN 46.15
- EPS
- ORGO N/A
- BSVN 4.71
- Revenue
- ORGO $458,760,000.00
- BSVN $96,026,000.00
- Revenue This Year
- ORGO $2.62
- BSVN N/A
- Revenue Next Year
- ORGO $12.46
- BSVN $3.53
- P/E Ratio
- ORGO N/A
- BSVN $8.54
- Revenue Growth
- ORGO 5.35
- BSVN 28.97
- 52 Week Low
- ORGO $2.28
- BSVN $29.06
- 52 Week High
- ORGO $6.71
- BSVN $50.26
- Technical
- Relative Strength Index (RSI)
- ORGO 54.42
- BSVN 61.37
- Support Level
- ORGO $3.13
- BSVN $37.56
- Resistance Level
- ORGO $3.36
- BSVN $39.39
- Average True Range (ATR)
- ORGO 0.21
- BSVN 0.96
- MACD
- ORGO 0.08
- BSVN 0.05
- Stochastic Oscillator
- ORGO 74.36
- BSVN 70.60
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About BSVN Bank7 Corp. Common stock
Bank7 Corp is a full-service commercial bank focused on providing customers with exceptional service and meeting their banking needs through a variety of commercial and retail financial services. It offers deposit banking products, including commercial deposit services, commercial checking, money market, and other deposit accounts, and retail deposit services such as certificates of deposit, money market accounts, checking accounts, negotiable order of withdrawal accounts, savings accounts, and automated teller machine access. etc. It generates revenues from interest income from financial instruments and non-interest income and service charges on deposit accounts.